Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
5.9%
% of VHT's 415 holdings also in MEDX
76.7%
% of MEDX's 30 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 18.6% | 12.0% |
|
JOHNSON & JOHNSON | 5.0% | 5.3% | 5.0% |
|
ABBVIE INC | 4.9% | 8.8% | 4.9% |
|
MERCK & CO. INC. | 3.3% | 3.5% | 3.3% |
|
AMGEN INC | 2.6% | 6.2% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 7.4% |
|
ABBOTT LABORATORIES | 4.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
GILEAD SCIENCES INC | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
DANAHER CORP | 2.1% |
|
STRYKER CORP | 2.1% |
 |
MEDTRONIC PLC | 1.9% |
VHT Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -7.0% |
|
ELI LILLY & CO | -6.7% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALKERMES PLC | -4.0% |
|
BRISTOL-MYERS SQUIBB CO | -4.0% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
ABBVIE INC | -3.9% |
|
AMGEN INC | -3.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |